UMass Amherst tick testing lab receives grant to study new disease

(University of Massachusetts at Amherst) Taking advantage of its special expertise in identifying tick-borne, disease-causing pathogens, plus its access the thousands of people who send ticks to be tested each year, the LMZ at UMass Amherst will partner with with L2 Diagnostics of New Haven, a biotech company that has developed a human test for Borrelia miyamotoi, one of the latest tick pathogens to emerge.

https://www.eurekalert.org/pub_releases/2017-10/uoma-uat101717.php

Source: EurekAlert! - Infectious and Emerging Diseases - October 17, 2017 Category: Infectious Diseases Source Type: news